Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :30191621
Publication Date : //

Predictive value of combined analysis of pro-NPY and ERG in localized prostate cancer.


This study aimed to investigate if combined analysis of pro-Neuropeptide Y (NPY) and ERG expression in tumor tissue are associated with biochemical failure (BF), castration-based treatment, castration-resistant prostate cancer (CRPC), and prostate cancer (PCa)-specific death for men undergoing radical prostatectomy (RP) for PCa. This study included 315 patients, who underwent RP from 2002 to 2005. Both pro-NPY and ERG expression were analyzed using immunohistochemistry and were scored as low or high and negative or positive, respectively. Risk of BF, castration-based treatment, CRPC, and PCa-specific death were analyzed with multiple cause-specific Cox regression analyses and stratified cumulative incidences using competing risk assessment. Median follow-up was 13.0 years (95% CI: 12.7-13.2). In total, 85.7% were pro-NPY high and 14.3% were pro-NPY low. The combined analyses of pro-NPY and ERG expression was not associated with risk of BF (p = 0.7), castration-based treatment (p = 0.8), CRPC (p = 0.4) or PCa-specific death (p = 0.5). In the multiple cause-specific Cox regression analysis, pro-NPY high and ERG positivity was not associated with BF (HR: 1.02; 95% CI 0.6-1.7; p = 0.94). In conclusion the combination of pro-NPY and ERG expression did not show association with risk of BF, castration-based treatment, CRPC, and PCa-specific death following RP.

Authors : Kristensen Gitte , Røder Martin Andreas , Berg Kasper Drimer , Elversang Johanna , Iglesias-Gato Diego , Moreira José , Toft Birgitte Grønkaer , Brasso Klaus ,

Related products :

Catalog number Product name Quantity
EIAAB40264 Homo sapiens,Human,Metalloreductase STEAP2,PCANAP1,Prostate cancer-associated protein 1,Protein upregulated in metastatic prostate cancer,PUMPCn,Six-transmembrane epithelial antigen of prostate 2,SixT
Prostate - PRC481 Prostate cancer tissue array contains 17 cases of pancreatic tumors and 7 cases of normal and reactive prostate tissues. 2mm
28-742 Two members of the human zinc finger Kruppel family, ZNF 12 (KOX 3) and ZNF 26 (KOX 20), have been localized by somatic cell hybrid analysis and in situ chromosomal hybridization. The presence of indi 0.1 mg
PR207b High_density prostate cancer (1_4 grade) and normal prostate tissue array, 70 cases_208 cores
BC19013 Prostate carcinoma (multi_tissue combined panel) tissue array, 33 cases_63 cores
PR721 Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases_72 cores
PR208 High_density (70 cases_208 cores), multiple prostate cancer (1_4 grade), normal prostate and placenta tissue array
PR2085b High_density (208 core) prostate adenocarcinoma (I_4 grade) and normal prostate (from autopsy and cancer adjacent) tissue BLOCK
PR2085a High_density (114 cases_208 cores) prostate adenocarcinoma (I_4 grade) and normal prostate (from autopsy and cancer adjacent) tissue array
PR481 Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases_48 cores, with grades, stages and Gleason scores
PR721 Prostate cancer normal prostate tissue array with TNM, grade and Gleason scores, 24 cases_72 cores; ihc Anti-Actin confirmed
BC19012 Prostate carcinoma (multi_tissue combined panel) tissue array, 33 cases_63 cores, replaced by PR808
PR207b High-density prostate cancer (1-4 grade) and normal prostate tissue array, 70 cases_208 cores, replaced by PR208; ihc P504S confirmed
T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases_24 cores
PR208 High-density prostate cancer tissue array(1-4 grade), normal prostate and placenta (as control), 70 cases_208 cores, replacing PR207b; ihc P504S confirmed
PR481 Prostate cancer tissue array with unmatched normal prostate tissues, 24 cases_48 cores, with grades, stages and Gleason scores; ihc Anti-Actin confirmed
PR807a Prostate cancer, hyperplasia and normal tissue array, including TNM and pathology grade, 79 cases_80 cores, replacing PR807; ihc Anti-Prostate Specific Antigen (PSA) confirmed
BC14012 Pancreatic cancer (multi_tissue combined panel), 24 cases_63 cores, replaced by PA721
PR2085a High-density (114 cases_208 cores) prostate adenocarcinoma (grade 1-4) and normal prostate (from autopsy and cancer adjacent) tissue array, replaced by PR2085b; ihc Anti-Actin confirmed
T191 Prostate cancer test tissue array, with normal prostate control tissues, including TNM, clinical stage and pathology grade, 6 cases_24 cores; ihc Anti-Actin confirmed
PR803 Prostate cancer tissue array with unmatched normal prostate tissue, 80 cases_80 cores, replacing PR801
PR801 Prostate cancer tissue array with unmatched normal prostate tissue, 78 cases_80 cores, replaced by PR803
1540 Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing PR242
1541 Prostate cancer tissue array with adjacent normal prostate tissue, including TNM, clinical stage and pathology grade, 12 cases_24 cores, replacing PR243
PRF281 Prostate cancer frozen tissue array, with grade and Gleason scores and normal prostate tissue control, 28 cases_28 cores; ihc H&E and Anti-Actin confirmed


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur